🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Localized Prostate Carcinoma

ABlative Radiotherapy (for) Unfavorable Prostate Tumors NCT04831983n/a1 site📍 Monza University of Milano Bicocca Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer NCT07344844NA1 site📍 Saint-Denis Clinique Sainte Clotilde · Tests: Low-dose CT imaging before each SBRT session PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site📍 Zamość Affidea Nu-med Center of Oncological DIagnostics and Therapy · Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachythe… Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners. NCT07351461n/a1 site📍 Lille University Hospital, Lille · Tests: Patient on active surveillance Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy NCT01961713n/a1 site📍 Boston Massachusetts General Hospital MRI-Guided Cryoablation for Focal Native Prostate Cancer NCT04797039n/a1 site📍 Rochester Mayo Clinic · Tests: MR guided cryoablation Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7% NCT07115992NA1 site📍 Shanghai Ruijin Hospital · Tests: RARP±SRT, RARP+ePLND High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma NCT04945642NA1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: High-Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy Focal Salvage Brachytherapy Study (FocaSaBra) NCT05715502NA1 site📍 Poznan The Greater Poland Cancer Centre · Tests: brachytherapy Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer NCT06990542Phase 21 site📍 La Jolla University of California, San Diego · Tests: Image-guided tumor-focused radiation therapy HCQ in Resectable Localized Prostate Cancer NCT06408298EARLY Phase 11 site📍 Lebanon Lionel.D.Lewis, MD · Tests: Hydroxychloroquine Sulfate 400Mg Tab, Placebo Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT NCT07455903Phase 21 site📍 Miami Baptist Health South Florida · Tests: Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer NCT07042256NA1 site📍 Zurich University of Zurich · Tests: Low-field MR-informed adaptive marker-less SBRT for definitive treatment of localized prostate cancer in patients with … Focal Therapy for Localized Prostate Cancer NCT06270043n/a1 site📍 La Jolla University of California, San Diego · Tests: Focal Therapy PSMA PET for Surveillance After Focal Therapy NCT07115914NA1 site📍 Chicago University of Chicago · Tests: PSMA PET/CT scan Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer NCT06613100Phase 19 sites📍 San Francisco📍 St Louis📍 Columbus Amgen · Tests: Xaluritamig, GnRH Antagonist Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H) NCT06461793Phase 21 site📍 Seoul Samsung Medical Center · Tests: Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients Circulating Tumor DNA in High Risk Localized Prostate Cancer NCT07222436n/a1 site📍 Pittsburgh University of Pittsburgh Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer NCT07526675NA1 site📍 Banhā Benha University · Tests: Bioblation Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation NCT05806515Phase 2133 sites📍 Anchorage📍 Anchorage📍 Anchorage SWOG Cancer Research Network · Tests: Biospecimen Collection, Carboplatin, Chest Radiography, Computed Tomography, Magnetic Resonance Imaging Stem Cells for Erectile Dysfunction Post RALP NCT07048314Phase 1, Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office, Allogeneic adipose-derived m… Effectiveness of Focal Therapy in Men With Prostate Cancer NCT06223295NA5 sites📍 Nijmegen📍 Etten-Leur📍 Amsterdam Radboud University Medical Center · Tests: Focal therapy, Usual care Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer. NCT07645872n/a5 sites📍 Aix-en-Provence📍 Besançon📍 Colmar EDAP TMS S.A. Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance NCT06733350Phase 41 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biopsy of Prostate, Biospecimen Collection, Magnetic Resonance Imaging, Patient Observation, Questionnaire Administrati… Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer NCT07184957n/a1 site📍 New York NYU Langone Health Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU NCT06945172NA1 site📍 Quint-Fonsegrives GCS Ramsay Santé pour l'Enseignement et la Recherche · Tests: Total prostatectomy, Focal HIFU RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer NCT06856694NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: NLP+AI Report Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial NCT06966778NA1 site📍 Taipei National Taiwan University Hospital · Tests: Oxybutynin chloride extended-release tablets 5mg/tab, 2 tab, PO, qd., Placebo (2 tab), PO, qd. PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT NCT07550517Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: EBRT + 6 mo ADT + 177Lu-PSMA-617, EBRT + 24 mo ADT Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy NCT06798558Phase 23 sites📍 Washington D.C.📍 Washington D.C.📍 Hackensack Hackensack Meridian Health · Tests: Lu-17-PSMA-617
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy